Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 21 Jun 2024 for 瑞康医药, €773k.
Filing timeline
BuySale烟台慧投投资发展合伙企业(有限合伙)
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +34.3%Entry CN¥2.16 · Close at T+365 CN¥2.90
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
烟台慧投投资发展合伙企业(有限合伙): trading record in brief
One trade, one date: on 21 June 2024, 烟台慧投投资发展合伙企业(有限合伙) disclosed an open-market purchase of €773k in 瑞康医药. No broader history exists yet. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.
Companies and markets linked to 烟台慧投投资发展合伙企业(有限合伙)
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
- 2,638,600 shares100.0% of flowA股XSHESZSE:173000007779437440Canonical exit: 19 Sept 2024 (T+90)
1 of 1 declaration